Efficacy and safety of CTLA‐4 inhibitors combined with PD‐1 inhibitors or chemotherapy in patients with advanced melanoma
Sign Up to like & getrecommendations! Published in 2019 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2018.12.034
Abstract: Background: Although immune checkpoint inhibitor monotherapy has demonstrated significant efficacy in advanced melanoma, no study has systematically evaluated the efficacy and safety of the combination regimens. In this study, we conduct a comprehensive meta‐analysis to… read more here.
Keywords: advanced melanoma; inhibitors plus; ctla inhibitors; safety ... See more keywords
PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030561
Abstract: Background: Metastatic melanoma treatment has drastically changed during the past decade with the advent of immunotherapy. We conducted a meta-analysis, to assess PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced… read more here.
Keywords: advanced melanoma; treatment; ctla inhibitors; meta analysis ... See more keywords